Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,796 | -9,982 | -5,677 | N/A | -8,353 |
| Depreciation Amortization | 3,242 | 2,399 | 1,569 | N/A | 2,533 |
| Other Working Capital | 1,063 | 198 | -28,759 | N/A | 688 |
| Other Operating Activity | 466 | 278 | 28,509 | 0 | -1,924 |
| Operating Cash Flow | $-7,025 | $-7,107 | $-4,358 | $N/A | $-7,056 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,669 | -2,302 | -1,413 | N/A | -3,586 |
| Other Investing Activity | 15,434 | 8,307 | 3,954 | 0 | 8,428 |
| Investing Cash Flow | $11,765 | $6,005 | $2,541 | $N/A | $4,842 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,715 | 3,151 | 2,475 | 0 | 1,460 |
| Financing Cash Flow | $4,715 | $3,151 | $2,475 | $N/A | $1,460 |
| Beginning Cash Position | 4,686 | 4,686 | 4,686 | N/A | 5,440 |
| End Cash Position | 14,141 | 6,735 | 5,345 | N/A | 4,686 |
| Net Cash Flow | $9,455 | $2,049 | $659 | $N/A | $-754 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,025 | -7,107 | -4,358 | N/A | -7,056 |
| Free Cash Flow | -7,025 | -7,107 | -4,358 | 0 | -7,056 |